Logo



 

  (format: symbol-exchange code e.g. IBM-N)

Exchange Codes:  T-Toronto N-New York A-American Q-Nasdaq I-Index
  • Stock Trends Report
  • Charting
  • Industry
  • Profile
  • Social
NYSE LLY     week ending
Friday Mar 15, 2019
   
Eli Lilly and Company
Trend Trend Counters Relative Strength  
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding.
Trend / Category
36/ 37
13 week Current wk Unusual Volume
102 -
n/a
  weeks in vs. S&P500  
Trading stats for the Week Stock Trends chart of Eli Lilly and Company $LLY - click for more ST charts
  Close Range
$US 123.94 118.84 - 126.19
1 week %change 13 week %change
-2.2% +10.7%
Average Price
13 week MA 40 week MA
119.42 108.82
52-week range
74.51 - 130.51
Share Volume Relative Volume
90,109,100 8.4%
Total traded value
$11,168,121,854
Historical ST Data | ST Charts
Eli Lilly and Company (LLY-N)
Trend Rel
Str
+
-
52wk
Hi | Lo
Stock Name
Symbol
Wk Close
Wk
%Chg
Wk
Range
Vol (00's)
Hi/Lo Vol
Drug Manufacturers - Major
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 11/41 88 + 114.98 | 75.77 AbbVie Inc. ABBV 81.34 +4.9 77.27 - 81.46 391050
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 3/19 113 - 74.75 | 32.18 Aerie Pharmaceuticals Inc. AERI 46.98 +1.7 45.42 - 50.08 52319
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 6/12 110 - 1.21 | 0.72 Alimera Sciences Inc. ALIM 1.17 +2.6 1.12 - 1.17 4325
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/6 95 - 5.24 | 1.55 Alliqua BioMedical Inc. ALQA 2.76 -21.6 2.76 - 3.54 19606
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 3/4 92 + 210.19 | 163.31 Amgen Inc. AMGN 191.24 +5.7 181.40 - 191.64 179889
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 6/98 100 - 42.61 | 34.11 Astrazeneca PLC AZN 42.51 +1.8 41.64 - 42.56 231402
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/11 97 + 388.67 | 249.17 Biogen Inc. BIIB 329.87 +7.1 307.28 - 330.10 74571
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/19 88 - 67.16 | 44.30 Bristol-Myers Squibb Company BMY 49.96 -2.8 48.79 - 51.55 979578
Bullish Crossover (aka 'Newly Bullish' Trend). The stock's Trend Category has changed from BEARISH to BULLISH. The 13-week MA, which was below the 40-week MA a week previous, has now moved above it. A stock in this sub-category is in the 1st week of its new BULLISH Trend Category. Trading implications: often considered a good trade entry signal. 1/1 119 + 95.30 | 58.59 Celgene Corporation CELG 88.46 +4.7 84.58 - 88.94 489647
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 9/11 147 - 2.65 | 0.11 Celgene Corporation Contingent Value Rig CELGZ 1.28 -8.6 1.10 - 1.65 4454 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them.
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 9/17 127 + 0.84 | 0.19 China Pharma Holdings Inc. CPHI 0.33 +10.0 0.29 - 0.34 12228
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 36/37 102 - 130.51 | 74.51 Eli Lilly and Company LLY 123.94 -2.2 118.84 - 126.19 901091
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 6/21 92 + 79.61 | 60.32 Gilead Sciences Inc. GILD 65.63 +3.8 62.47 - 65.79 366492
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/17 100 - 42.36 | 36.13 GlaxoSmithKline PLC GSK 40.63 +1.3 39.82 - 40.64 79131
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/48 94 - 24.97 | 17.42 Grifols S.A. GRFS 19.20 -1.2 18.98 - 19.42 40674
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 9/13 130 + 182.23 | 90.14 GW Pharmaceuticals Plc GWPH 169.32 +3.8 163.46 - 174.07 15520
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 3/13 76 + 39.68 | 20.83 Hutchison China MediTech Limited HCM 27.92 +3.8 26.57 - 28.78 7280
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/3 95 - 148.99 | 118.62 Johnson & Johnson JNJ 137.60 -0.3 136.83 - 140.00 385671
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 7/39 98 - 82.12 | 52.83 Merck & Company Inc. (new) MRK 81.57 +2.2 79.53 - 81.91 499231
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/73 83 - 0.92 | 0.20 NanoViricides Inc. NNVC 0.27 -6.9 0.26 - 0.32 11862
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 12/26 98 + 93.62 | 72.30 Novartis AG NVS 93.29 +4.0 89.55 - 93.62 98005
Bearish Crossover (aka 'Newly Bearish' Trend). The stock's Trend Category has changed from BULLISH to BEARISH. The 13-week MA, which was above the 40-week MA a week previous, has now moved below it. A stock exhibiting this Trends Symbol is in the 1st week of its new BEARISH Trend Category. Trading implications: generally considered a trade exit signal. 1/1 72 - 5.70 | 1.20 Oasmia Pharmaceutical AB OASM 2.70 +1.9 2.53 - 2.76 168 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks.
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 1/37 88 - 46.47 | 34.32 Pfizer Inc. PFE 41.78 +2.2 40.80 - 42.13 1745120
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 2/5 93 + 6.64 | 2.60 ProPhase Labs Inc. PRPH 3.18 +4.3 2.70 - 3.18 528
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/16 88 + 33.00 | 19.77 Retrophin Inc. RTRX 22.87 +8.7 21.13 - 23.22 20877
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 6/73 152 + 6.55 | 2.19 Rockwell Medical Inc. RMTI 5.21 +3.0 4.42 - 5.25 23409
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/3 94 + 45.62 | 37.43 Sanofi SNY 45.09 +5.1 43.10 - 45.15 56148
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 3/13 88 - 0.60 | 0.15 Sanofi Contingent Value Right (Expiring GCVRZ 0.45 -2.2 0.34 - 0.47 3575
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 10/22 130 - 7.66 | 3.51 TherapeuticsMD Inc. TXMD 5.46 -4.2 5.43 - 5.82 152760
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 7/17 115 - 62.75 | 33.43 Zogenix Inc. ZGNX 51.88 +1.8 50.87 - 54.49 24728
Highlighted stocks traded at their 52 week high or low, OR gained/lost more than 10% during the trading week.
Business Description :
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. It operates through two segments, Human Pharmaceutical Products and Animal Health Products. The company offers endocrinology products to treat diabetes; osteoporosis in postmenopausal women and men; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency. It also provides neuroscience products for the treatment of major depressive disorders, diabetic peripheral neuropathic pain, anxiety disorders, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorders; depressive, obsessive-compulsive, bulimia nervosa, and panic disorders; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains. In addition, the company offers products for the treatment of non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products for the treatment of erectile dysfunction and benign prostatic hyperplasia, thrombotic cardiovascular events, and cardiac ischemic complications. Further, it provides animal health products, such as cattle feed additives; protein supplements for cows; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; anticoccidial agents for poultry; and chewable tablets that kill fleas and prevent flea infestations, heartworm diseases, roundworm diseases, hookworm diseases, and whipworm diseases. Additionally, the company offers products to treat chronic manifestations of atopic dermatitis and congestive heart failure in dogs; chronic allergic dermatitis and kidney diseases in cats. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Company Website :
  Privacy Policy  |   Terms of Use  |   Syndications  |   Contact Us